Manon Paradis

Professor (directory)


  • D.V.M., Université de Montréal (1979)
  • Internship, small animal medicine and surgery, University of Montreal (1980)
  • Residency, small animal internal medicine, University of Saskatchewan (1982)
  • Master degree in veterinary sciences, University of Saskatchewan (1982)
  • Alternative residency program in Veterinary dermatology, University of Montreal and Cornell University (1990)
  • Diplomate of American College of Veterinary Dermatology (1990)

Professional activities

  • Teaching veterinary dermatology to undergraduate and post graduate veterinary students, Department of Clinical Sciences, FMV
  • Clinician, Veterinary Dermatology Service CHUV (see dermatology site)
  • Director of Companion Animal Research group (GRAC), FMV (2003-2012)
  • Director of companion animal health Funds (FSAC), CHUV (2005-2012)
  • GRAC researcher
  • Canadian representative of WCVDA
  • Member of : ACVD, AACD, CAVD, ESVD et WCVDA
  • President of the 7th World congress of veterinary dermatology (Vancouver 2012)

Professional and research interests

  • Canine thyroid function
  • Treatment of parasitic acarioses in companion animals
  • Use of melatonin in the treatment of diverse canine alopecic disorders
  • Genodermatoses


  • American Association of Feline Practitioners (1980)
  • SmithKline Beecham award for research excellence (1994)
  • Damase Généreux award, AMVQ (2000)
  • Small animal practitioner award, ACMV (2003)
  • Prix de la Fédération des associations francophones des vétérinaires d’animaux de compagnie (2008)

Dr Manon Paradis is professor in veterinary dermatology at the Faculté de médecine vétérinaire (FMV) of the University of Montreal. In addition to her clinical, teaching and administrative responsibilities, Dr Paradis is very active in research and continuing education. She is author and co-author of over 100 scientific articles and 30 book chapters, and has given over 200 continuing education lectures at local, national and international meetings.Her fields of interest include the use of avermectins and melatonin in small animal dermatology, thyroid function in dogs and genodermatoses.

Her most significant research results are mainly from clinical research. Over the years, she has conducted or directed several research projects exploring canine thyroid function. Seven of those projects involved graduate students who were either evaluating the influence of diseases or drugs on canine thyroid function, comparing various diagnostic methods or evaluating the use of recombinant human TSH as an aid in the diagnosis of canine hypothyroidism.

In addition, Dre Paradis has evaluated the use of several drugs in veterinary dermatology (e.g. nonsteroidal antipruritic drugs, antibiotics, topical antifungal, off-label use of ivermectin, melatonin, etc.). The vast majority of these clinical trials were not sponsored by pharmaceutical companies. She was the first one to promote the daily oral use of ivermectin in the treatment of generalized canine demodicosis, which is currently the most wildly use treatment modality in this disease. Her clinical observations have also allowed a better understanding some clinical entities in dogs (e.g. canine recurrent flank alopecia, pattern alopecia, alopecia X), and results obtained in clinical trials with melatonin have promote the use of this treatment in various acquired alopecic disorders in dogs.

Her clinical observations have also allowed her to observed, described and report five new dermatologic disorders in animals: hereditary seborrhea oleosa in Persan cats; hereditary foot pad hyperkeratosis in Dogues de Bordeaux; linear epidermal névi in Belgium horses; hereditary nasal parakeratosis in Labrador retrievers and; acral mutilation syndrome in French spaniels.


© Faculté de médecine vétérinaire. Université de Montréal | Webmestre| Pour nous joindre